Trial
NCT05306353
CD40L Antagonism in Rheumatoid Arthritis (RA)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Immune Tolerance Network (ITN)
Condition
Rheumatoid Arthritis
Intervention
Placebo for VIB4920
Why stopped
The study is being closed early due to insufficient participant enrollment across study sites.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-29